SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X, Liang R, Liu C, Liu JA, Cheung MPL, Liu X, Man OY, Guan XY, Lung HL, Cheung M.
Yang X, et al. Among authors: liu x, liu ja, liu c.
J Exp Clin Cancer Res. 2019 Jan 14;38(1):17. doi: 10.1186/s13046-018-0998-6.
J Exp Clin Cancer Res. 2019.
PMID: 30642390
Free PMC article.